PHONE: 720.213.5828

Jenel Stelton-Holtmeier

Jenel’s journalism experience began two decades ago at her hometown newspaper in Wahpeton, North Dakota. For the past decade, she wrote and edited for a B2B publication and focused on analyzing management, strategy and trends for business owners and executives, ranging from best practices around M&A to how businesses can adapt to demographic shifts in the workforce. Her work earned several editorial excellence awards from the Specialized Information Publishers Association.

Earnings roundup: Charlotte’s Web sales up 57%; GW Pharmaceuticals losses widen

CBD product sales boosted Charlotte’s Web Holdings’ revenues in the third quarter, while CBD drugmaker GW Pharmaceuticals saw its losses widen on lagging sales in its fiscal fourth quarter and full year. Charlotte’s Web (CSE: CWEB) reported revenue grew 57% to $17.7 million compared with last year’s $11.3 million during the same quarter. Year-to-date revenue […]

Read More

Cannabis tech firm Eaze opens online CBD marketplace to meet growing demand

San Francisco-based tech company Eaze launched a new online marketplace, Eaze Wellness, to ship hemp-derived CBD products to 41 states across the U.S. and the District of Columbia. CBD sales more than doubled among the company’s customers last year, Sheena Shiravi, Eaze’s director of consumer communications, told Fortune, highlighting a key business opportunity. This marks the company’s […]

Read More

New Zealand legalizes hempseed as food, issues guidelines

A regulatory change in New Zealand has opened the doors to hemp as food in the island nation. “Hempseeds are safe to eat and nutritious,” Bryan Wilson, head of New Zealand Food Safety, said in the announcement about the changes that now allow the sale of hempseed foods. The new guidance is being embraced by hemp […]

Read More

MariMed invests $30M in hemp-derived CBD producer

Massachusetts-based MariMed, a multistate cannabis operator, is entering the hemp-derived CBD business with a $30 million investment in a Kentucky company. The company, GenCanna, has contract farmers to grow hemp to its specifications as well as processing facilities to make CBD extracts, concentrates, isolates and other products. GenCanna plans to use the investment to expand […]

Read More

CBD manufacturer Mile High Labs closes $35 million Series A funding round

Loveland, Colorado-based Mile High Labs – a manufacturer of CBD crude oil, distillate and isolate – closed a $35 million Series A funding round as it works to expand its operations. The raise was led by institutional investors from the United States and Europe, as well as family offices and a venture capital fund. The company […]

Read More

GW Pharmaceuticals poised to raise $300 million in stock offering

Cannabis biopharmaceutical company  GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals […]

Read More

Oregon marijuana growers eye opportunities in hemp

As Oregon cannabis prices continue to sink to new lows amid a product glut, outdoor marijuana growers are turning their sights to MJ’s cousin: hemp.

The pivot allows growers to diversify their revenue stream and capitalize on a crop that could soon become legal at the federal level – thanks to the 2018 Farm Bill pending before Congress.

Read More

Hemp dispute may be harbinger of approaching legal storm

Two companies are in a legal tussle over what destroyed a 600-acre hemp farming joint venture in Colorado – a conflict that industry experts say could be the first of many as eager investors and firms try to cash in on budding business opportunities. In a recent California Superior Court filing, California-based H2 Partners claims that […]

Read More

Hemp Notebook: Hemp’s scramble to distance itself from marijuana veers into misinformation

(This is an abridged version of a column that appears in the July issue of Marijuana Business Magazine.) Not all hemp misinformation comes from anti-drug enemies of cannabis; some of it comes from hemp acolytes themselves. A recent comment from hemp’s most powerful friend in Congress, Senate Majority Leader Mitch McConnell, drove home for me a […]

Read More

Maine CBD executive settles SEC complaint for $390,000

The founder of a Maine-based CBD company will pay more than $390,000 to settle charges by the U.S. Securities and Exchange Commission that he advertised sales of unregistered securities on Craigslist. The SEC complaint alleges that, beginning in 2014, Richard Greenlaw of Kittery, Maine, raised approximately $500,000 from at least 59 investors by offering securities […]

Read More

Stricter regulations stifle Michigan CBD market

CBD processing and sales are still legal in Michigan, but now they must be conducted within the revised, regulated medical marijuana market – at a cost many producers see as too high. Rick Thompson, a board member at the Michigan affiliate of the National Organization for the Reform of Marijuana Laws (NORML), said the May […]

Read More